Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kiyoi

Showing results (71-80 of 270) with videos related to

Pageof 27
Sort By:
Scientific Reports|August 18, 2015
Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cellsKeiki Sugimoto, Fumihiko Hayakawa, Satoko Shimada, et al.
Cancer Science|June 28, 2016
SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathwayYusuke Takagi, Kazuyuki Shimada, Satoko Shimada, et al.
International Journal of Hematology|September 18, 2024
Newly diagnosed multiple myeloma with bleeding and coagulation abnormalities caused by a thrombin-inhibiting substanceFumiya Ohara, Atsuo Suzuki, Nobuaki Suzuki, et al.
Experimental Hematology|May 29, 2012
CML cells expressing the TEL/MDS1/EVI1 fusion are resistant to imatinib-induced apoptosis through inhibition of BAD, but are resensitized with ABT-737Kazuyuki Shimada, Akihiro Tomita, Yosuke Minami, et al.
Journal of Geriatric Oncology|August 14, 2017
Clinical effectiveness of geriatric assessment for predicting the tolerability of outpatient chemotherapy in older adults with cancerNaomi Hayashi, Ayumu Matsuoka, Hidemi Goto, et al.
Cancer Science|July 15, 2016
Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction deviceAyumu Matsuoka, Ayako Mitsuma, Osamu Maeda, et al.
Journal for Immunotherapy of Cancer|March 11, 2026
CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesisYuki Takeuchi, Seitaro Terakura, Kohei Ishigiwa, et al.
Blood|February 28, 2009
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significanceJunji Hiraga, Akihiro Tomita, Takumi Sugimoto, et al.
Internal Medicine (Tokyo, Japan)|April 6, 2006
Micafungin, a novel antifungal agent, as empirical therapy in acute leukemia patients with febrile neutropeniaMasamitsu Yanada, Hitoshi Kiyoi, Makoto Murata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 5, 2023
[Cellular kinetics and outcome of tisagenlecleucel for diffuse large B-cell lymphoma]Ryo Hanajiri, Katsuya Furukawa, Marie Nakashima, et al.
Pageof 27

Showing results (71-80 of 270) with videos related to

Sort By:
Pageof 27
Scientific Reports|August 18, 2015
Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cellsKeiki Sugimoto, Fumihiko Hayakawa, Satoko Shimada, et al.
Cancer Science|June 28, 2016
SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathwayYusuke Takagi, Kazuyuki Shimada, Satoko Shimada, et al.
International Journal of Hematology|September 18, 2024
Newly diagnosed multiple myeloma with bleeding and coagulation abnormalities caused by a thrombin-inhibiting substanceFumiya Ohara, Atsuo Suzuki, Nobuaki Suzuki, et al.
Experimental Hematology|May 29, 2012
CML cells expressing the TEL/MDS1/EVI1 fusion are resistant to imatinib-induced apoptosis through inhibition of BAD, but are resensitized with ABT-737Kazuyuki Shimada, Akihiro Tomita, Yosuke Minami, et al.
Journal of Geriatric Oncology|August 14, 2017
Clinical effectiveness of geriatric assessment for predicting the tolerability of outpatient chemotherapy in older adults with cancerNaomi Hayashi, Ayumu Matsuoka, Hidemi Goto, et al.
Cancer Science|July 15, 2016
Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction deviceAyumu Matsuoka, Ayako Mitsuma, Osamu Maeda, et al.
Journal for Immunotherapy of Cancer|March 11, 2026
CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesisYuki Takeuchi, Seitaro Terakura, Kohei Ishigiwa, et al.
Blood|February 28, 2009
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significanceJunji Hiraga, Akihiro Tomita, Takumi Sugimoto, et al.
Internal Medicine (Tokyo, Japan)|April 6, 2006
Micafungin, a novel antifungal agent, as empirical therapy in acute leukemia patients with febrile neutropeniaMasamitsu Yanada, Hitoshi Kiyoi, Makoto Murata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 5, 2023
[Cellular kinetics and outcome of tisagenlecleucel for diffuse large B-cell lymphoma]Ryo Hanajiri, Katsuya Furukawa, Marie Nakashima, et al.
Pageof 27